CLINICAL_TRIALS
trial_result
· 2022-10-04
Clinical Trial Update: A Study to Test if TV-46000 is Safe for Maintenance Treatment of Schizophrenia [Phase 3]
Summary
Phase 3 trial completed evaluating TV-46000 for maintenance treatment in schizophrenia; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2022-10-04